New Drug Discovery

  • NATCO is one of the few Indian companies to venture into New Drug Discovery
  • We have promising molecules in R&D pipeline, especially in the Oncology segment
  • One of the molecules, NRC-AN-019, received Orphan Designation for CML, Glioma and Pancreatic Cancer indications from USFDA in February, 2011